Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medistep HealthcareNSE:MEDISTEP +5.74%19 Shareholder Yield % is -56.21% as of Sep. 2025. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 113 Medical Distribution companies, Medistep Healthcare ranks worse than 98.23% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Medistep Healthcare's Shareholder Yield % was -56.21%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Medistep Healthcare Shareholder Yield % Related Terms
Medistep Healthcare Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDISTEP vs MCK, CAH, COR: Shareholder Yield % Comparison
For the Medical Distribution subindustry, Medistep Healthcare's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare Shareholder Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Medistep Healthcare (NSE:MEDISTEP) has a Shareholder Yield % of -56.21% as of Sep. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Medistep Healthcare and its competitors. According to the industry distribution chart, Medistep Healthcare ranks #111 out of 113 companies in the Medical Distribution industry, placing it in the top 98.2%.
Is Medistep Healthcare's Shareholder Yield % too high?
Medistep Healthcare's current Shareholder Yield % is -56.21%. Based on the distribution chart, Medistep Healthcare ranks #111 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's Shareholder Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #111 out of 113 companies for Shareholder Yield %. This places Medistep Healthcare in the lower half of its industry. The industry median Shareholder Yield % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Distribution company?
The median Shareholder Yield % among Medical Distribution companies is 2.40, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median Shareholder Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current Shareholder Yield % is -56.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current Shareholder Yield % of -56.21%. The current Shareholder Yield % is -56.21%. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current Shareholder Yield % is -56.21% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 
